No device related mortality at one year for India’s first trancatheter heart valve

Ashok Seth (New Delhi, India) talks to BLearning at EuroPCR 2019 (21–24 May, Paris, France) about the MyVal-1 study which looked at the one-year clinical outcomes of India’s first indigenously designed and manufactured TAVR system. This was the first in-human study of the device which was performed as per the regulatory authorities of India.

Seth outlines the key findings from the one-year data which showed that survival – which was the primary endpoint of the study – was 85% in those patients who were intermediate and high risk for surgical valve replacement. This, claims Seth, is the “normally expected survival rate of the best of the valves at one-year”.

There were no device-related complications or mortality, says Seth, who notes that “on all fronts the valve performed well and met the endpoints of safety and efficacy”. Increased innovation in India and emerging countries, he adds, can help bring down the cost of TAVR procedures on a global scale.

Seth, Ashok

Ashok Seth is the current Chairman of Fortis Escorts Heart Institute, New Delhi and Head, Cardiology Council of Fortis Group of Hospitals. His contributions in the field of Cardiology, especially Interventional Cardiology have been recognised extensively in India as well as across the world. During his career span of 30-years, he has pioneered numerous angioplasty techniques Directional Atherectomy, Angioscopy, Stents, Thrombectomy devices and Drug Eluting Stents, use of Impella heart support device failing heart, Bioabsorbable Stents and TAVI and implemented it successfully both in India and other regions in Asia Pacific. He has performed one of the highest number of angiographies and angioplasties which has been mentioned in the 'LIMCA Book of Records'.

Dr. Seth has been the President of the Cardiological Society of India and Vice President of the Asian Pacific Society of Cardiology. He was elected Board of Trustee of SCAI (USA) for the period 2007-2010 and is presently a member of the SCAI Nominating Committee and Voting Selector of the MSCAI Nominating Committee. He has been invited to lecture on and demonstrate complex angioplasty techniques in more than 400 international training courses and meetings across the globe including live transmissions of complex cases from India to the TCT and EuroPCR Meetings. He is on the Editorial Board of JACC Cardiovascular Interventions, CCI, Euro Intervention, Indian Heart Journal and others.

Add comment

Editor’s Cardiovascular Pick

    Subscribeto receive the very best in medical videos